GGrantIndex
← Leaderboards

Andrew H Liu

National Jewish Health

$4,764,663
Attributed
$4,764,663
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $820K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,764,663 · 7

By mechanism

P01$2,459,601 · 2
U01$1,684,565 · 1
K23$612,090 · 1
M01$8,407 · 3

Top collaborators

No co-investigators on record.

Most similar at National Jewish Health

Same institution · by research overlap

Others in their field

Top investigators on “Asthma

Research focus

AsthmaChildResearch PersonnelUrban ChildrenSamplingNovel StrategiesLungNoseEosinophilAffectRecording Of Previous EventsResponseFunctional DisorderPreventPhenotypeInsightPhysiologyPublic HealthChildhoodAtopyChildhood AsthmaImmune ResponseCollaborationsGenetic Transcription

Grant awards (23)

Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers$343,768
U01 · FY2025 · AI · contact PI
Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers$345,774
U01 · FY2024 · AI · contact PI
Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers$339,644
U01 · FY2023 · AI · contact PI
Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers$326,021
U01 · FY2022 · AI · contact PI
Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers$329,358
U01 · FY2021 · AI · contact PI
Clinical Core: Exacerbation-Prone Pediatric Asthmatics and Control Populations$283,106
P01 · FY2021 · HL · contact PI
Environmental Determinants of Asthma Exacerbation in Children$207,514
P01 · FY2021 · HL · contact PI
Clinical Core: Exacerbation-Prone Pediatric Asthmatics and Control Populations$283,106
P01 · FY2020 · HL · contact PI
Environmental Determinants of Asthma Exacerbation in Children$207,514
P01 · FY2020 · HL · contact PI
Clinical Core: Exacerbation-Prone Pediatric Asthmatics and Control Populations$283,106
P01 · FY2019 · HL · contact PI
Environmental Determinants of Asthma Exacerbation in Children$207,514
P01 · FY2019 · HL · contact PI
Clinical Core: Exacerbation-Prone Pediatric Asthmatics and Control Populations$284,628
P01 · FY2018 · HL · contact PI
Environmental Determinants of Asthma Exacerbation in Children$207,514
P01 · FY2018 · HL · contact PI
Clinical Core: Exacerbation-Prone Pediatric Asthmatics and Control Populations$288,085
P01 · FY2017 · HL · contact PI
Environmental Determinants of Asthma Exacerbation in Children$207,514
P01 · FY2017 · HL · contact PI
COFAR-2$3,204
M01 · FY2008 · RR · contact PI
COFAR 3 EGG ORAL IMMUNOTHERAPY$1,107
M01 · FY2008 · RR · contact PI
ENDOTOXIN AND ASTHMA PREVENTION IN YOUNG CHILDREN$122,418
K23 · FY2005 · HL
ENDOTOXIN AND ASTHMA PREVENTION IN YOUNG CHILDREN$122,418
K23 · FY2004 · HL
The Prevention of Chronic Asthma in Young Children$4,096
M01 · FY2004 · RR
ENDOTOXIN AND ASTHMA PREVENTION IN YOUNG CHILDREN$122,418
K23 · FY2003 · HL
ENDOTOXIN AND ASTHMA PREVENTION IN YOUNG CHILDREN$122,418
K23 · FY2002 · HL
ENDOTOXIN AND ASTHMA PREVENTION IN YOUNG CHILDREN$122,418
K23 · FY2001 · HL